Prion Diseases
1995; Wiley; Volume: 39; Issue: 12 Linguagem: Inglês
10.1111/j.1348-0421.1995.tb03288.x
ISSN1348-0421
Autores Tópico(s)Trace Elements in Health
ResumoMicrobiology and ImmunologyVolume 39, Issue 12 p. 923-928 ArticleFree Access Prion Diseases Jun Tateishi, Jun Tateishi Department of Neuropathology, Neurological Institute, Faculty of Medicine, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, Fukuoka, 812-82 JapanSearch for more papers by this author Jun Tateishi, Jun Tateishi Department of Neuropathology, Neurological Institute, Faculty of Medicine, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, Fukuoka, 812-82 JapanSearch for more papers by this author First published: December 1995 https://doi.org/10.1111/j.1348-0421.1995.tb03288.xCitations: 2AboutSectionsPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Abbreviations CJD Creutzfeldt-Jakob disease FFI fatal familial insomnia GSS Gerstmann-Sträussler-Scheinker syndrome ORF open reading frame PK proteinase K Prn-p mouse prion protein gene PrP prion protein PrPc cellular isoform of prion protein PrPScCJD abnormal (infectious) isoform of prion protein, Substitution of amino acid is written as, for example, P102L which means substitution of a leucine (L) for proline (P) at codon 102. References 1Bessen, R.A., Kocisko, D.A., Raymond, G.J., Nandan, S., Lansbury, P.T., and Caughey, B. 1995. Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature 375: 698– 700. CrossrefCASPubMedWeb of Science®Google Scholar 2Brown, P., Gibbs, C.J., Jr., Rodgers-Johnson, P., Asher, D.M., Sulima, M.P., Bacote, A., Goldfarb, L.G., and Gajdusek, D.C. 1994. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann. Neurol. 35: 513– 529. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar 3Büeler, H., Fischer, M., Lang, Y., Bluethmann, H., Lipp, H.-P., DeArmond, S.J., Prusiner, S.B., Aguet, M., and Weissmann, C. 1992. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356: 577– 582. CrossrefCASPubMedWeb of Science®Google Scholar 4Büeler, H., Aguzzi, A., Sailer, A., Greiner, R.-A., Autenried, P., Aguet, M., and Weissmann, C. 1993. Mice devoid of PrP are resistant to scrapie. Cell 73: 1339– 1347. CrossrefCASPubMedWeb of Science®Google Scholar 5Caughey, B.W., Dong, A., Bhat, K.S., Ernst, D., Hayes, S.F., and Caughey, W.S. 1991. Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry 30: 7672– 7680. CrossrefCASPubMedWeb of Science®Google Scholar 6Collinge, J., Whittington, M.A., Sidle, K.C.L., Smith, C.J., Palmer, M.S., Clarke, A.R., and Jefferys, J.G.R. 1994. Prion protein is necessary for normal synaptic function. Nature 370: 295– 297. CrossrefCASPubMedWeb of Science®Google Scholar 7DeArmond, S.J., and Prusiner, S.B. 1995. Etiology and pathogenesis of prion diseases. Am. J. Pathol. 146: 785– 811. CASPubMedWeb of Science®Google Scholar 8Doh-ura, K., Tateishi, J., Sasaki, H., Kitamoto, T., and Sakaki, Y. 1989. Pro→Leu change at position 102 of prion protein is the most common but not the sole mutation related to Gerstmann-Sträussler syndrome. Biochem. Biophys. Res. Commun. 163: 974– 979. CrossrefCASPubMedWeb of Science®Google Scholar 9Doh-ura, K., Kitamoto, T., Sakaki, Y., and Tateishi, J. 1991. CJD discrepancy. Nature 353: 801– 802. CrossrefCASPubMedWeb of Science®Google Scholar 10Gajdusek, D.C., Gibbs, C.J., Jr., and Alpers, M. 1966. Experimental transmission of a kuru-like syndrome to chimpanzees. Nature 209: 794– 796. CrossrefCASPubMedWeb of Science®Google Scholar 11Gasset, M., Baldwin, M.A., Lloyd, D., Gabriel, J.-M., Holtzman, D.M., Cohen, F., Fletterick, R., and Prusiner, S.B. 1992. Predicted α-helical regions of the prion protein when synthesized as peptides form amyloid. Proc. Natl. Acad. Sci. U.S.A. 89: 10940– 10944. Google Scholar 12Gasset, M., Baldwin, M.A., Fletterick, R.J., and Prusiner, S.B. 1993. Perturbation of the secondary structure of the scrapie prion protein under conditions associated with changes in infectivity. Proc. Natl. Acad. Sci. U.S.A. 90: 1– 5. CrossrefCASPubMedWeb of Science®Google Scholar 13Hsiao, K., Baker, H.F., Crow, T.J., Poulter, M., Owen, F., Terwilliger, J.D., Westaway, D., Otto, J.P., and Prusiner, S.B. 1989. Linkage of a prion protein missense variant to Gerstmann-Sträussler syndrome. Nature 338: 342– 345. CrossrefCASPubMedWeb of Science®Google Scholar 14Hsiao, K.K., Scott, M., Foster, D., Groth, D.F., DeArmond, S.J., and Prusiner, S.B. 1990. Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 250: 1587– 1590. CrossrefCASPubMedWeb of Science®Google Scholar 15Hsiao, K.K., Groth, D., Scott, M., Yang, S.-L., Serban, H., Rapp, D., Foster, D., Torchia, M., DeArmond, S.J., and Prusiner, S.B. 1994. Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. Proc. Natl. Acad. Sci. U.S.A. 91: 9126– 9130. CrossrefCASPubMedWeb of Science®Google Scholar 16Kitamoto, T., Ogomori, K., Tateishi, J., and Prusiner, S.B. 1987. Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab. Invest. 57: 230– 236. CASPubMedWeb of Science®Google Scholar 17Kitamoto, T., and Tateishi, J. 1988. Immunohistochemical confirmation of Creutzfeldt-Jakob disease with a long clinical-course with amyloid plaque core antibodies. Am. J. Pathol. 131: 435– 443. CASPubMedWeb of Science®Google Scholar 18Kitamoto, T., Shin, R.-W., Doh-ura, K., Tomokane, N., Miyazono, M., Muramoto, T., and Tateishi, J. 1992. Abnormal isoform of prion protein accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease. Am. J. Pathol. 140: 1285– 1294. CASGoogle Scholar 19Kocisko, D.A., Come, J.H., Priola, S.A., Chesebro, B., Raymond, G.J., Lansbury, P.T., Jr., and Caughey, B. 1994. Cell-free formation of protease-resistant prion protein. Nature 370: 471– 474. CrossrefCASPubMedWeb of Science®Google Scholar 20Kocisko, D.A., Priola, S.A., Raymond, G.J., Chesebro, B., Lansbury, P.T., and Caughey, B. 1995. Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier. Proc. Natl. Acad. Sci. U.S.A. 92: 3923– 3927. CrossrefCASPubMedWeb of Science®Google Scholar 21Kretzschmar, H.A., Honold, G., Seitelberger, F., Feucht, M., Wessely, P., Mehraein, P., and Budka, H. 1991. Prion protein mutation in family first reported by Gerstmann, Sträussler, and Scheinker. Lancet 337: 1160. CrossrefCASPubMedWeb of Science®Google Scholar 22Manson, J., West, J.D., Thomson, V., McBride, P., Kaufman, M.H., and Hope, J. 1992. The prion protein gene: a role in mouse embryogenesis? Development 115: 117– 122. CASPubMedWeb of Science®Google Scholar 23Medori, R., Tretschler, H.-J., LeBlanc, A., Villare, F., Manetto, V., Chen, H.Y., Xue, R., Leai, S., Montagna, P., Gortelli, P., Tinuper, P., Avoni, P., Mochi, M., Baruzzi, A., Hauw, J.J., Otto, J., Lugaresi, E., Autilio-Gambetti, L., and Gambetti, P. 1992. Fatal familial insomnia, a prion diease with a mutation at codon 178 of the prion protein gene. N. Engl. J. Med. 326: 444– 449. CrossrefCASPubMedWeb of Science®Google Scholar 24Muramoto, T., Kitamoto, T., Tateishi, J., and Goto, I. 1992. Successful transmission of Creutzfeldt-Jakob disease from human to mouse verified by prion protein accumulation in mouse brains. Brain Res. 599: 309– 316. CrossrefCASPubMedWeb of Science®Google Scholar 25Muramoto, T., Kitamoto, T., Hoque, M.Z., Tateishi, J., and Goto, I. 1993. Species barrier prevents an abnormal isoform of prion protein from accumulating in follicular dendritic cells of mice with Creutzfeldt-Jakob disease. J. Virol. 67: 6808– 6810. CASPubMedWeb of Science®Google Scholar 26Nguyen, J., Baldwin, M.A., Cohen, F.E., and Prusiner, S.B. 1995. Prion protein peptides induce α-helix to β-sheet conformational transitions. Biochemistry 34: 4186– 4192. CrossrefCASPubMedWeb of Science®Google Scholar 27Oesch, B., Westaway, D., Wälchli, M., McKinley, M.P., Kent, S.B.H., Aebersold, R., Barry, R.A., Tempst, P., Teplow, D.B., Hood, L.E., Prusiner, S.B., and Weissmann, C. 1985. A cellular gene encodes scrapie PrP 27-30 protein, Cell 40: 735– 746. CrossrefCASPubMedWeb of Science®Google Scholar 28Pan, K.-M., Baldwin, M., Nguyen, J., Gasset, M., Serban, A., Groth, D., Mehlhorn, I., Huang, Z., Fletterick, R.J., Cohen, F.E., and Prusiner, S.B. 1993. Conversion of α-helices into β-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. U.S.A. 90: 10962– 10966. CrossrefCASPubMedWeb of Science®Google Scholar 29Prusiner, S.B., Scott, M., Foster, D., Pan, K.-M., Groth, D., Mirenda, C., Torchia, M., Yang, S.-L., Serban, D., Carison, G.A., Hoppe, P.C., Westaway, D., and DeArmond, S.J. 1990. Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 63: 673– 686. CrossrefCASPubMedWeb of Science®Google Scholar 30Prusiner, S.B. 1991. Molecular biology of prion disease. Science 252: 1515– 1522. CrossrefCASPubMedWeb of Science®Google Scholar 31Prusiner, S.B., Groth, D., Serban, A., Koehler, R., Foster, D., Torchia, M., Burton, D., Yang, S.-L., and DeArmond, S.J. 1993. Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc. Natl. Acad. Sci. U.S.A. 90: 10608– 10612. CrossrefCASPubMedWeb of Science®Google Scholar 32Scott, M., Foster, D., Mirenda, C., Serban, D., Coufal, F., Wälchli, M., Torchia, M., Groth, D., Carlson, G., DeArmond, S.J., Westaway, D., and Prusiner, S.B. 1989. Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell 59: 847– 857. CrossrefCASPubMedWeb of Science®Google Scholar 33Scott, M., Groth, D., Foster, D., Torchia, M., Yang, S.-L., DeArmond, S.J., and Prusiner, S.B. 1993. Propagation of prions with artificial properties in transgenic mice expressing chimeric PrP genes. Cell 73: 979– 988. CrossrefCASPubMedWeb of Science®Google Scholar 34Sparkes, R.S., Simon, M., Cohn, V.H., Fournier, R.E.K., Lem, J., Klisak, I., Heinzmann, C., Blatt, C., Lucero, M., Mohandas, T., DeArmond, S.J., Westaway, D., Prusiner, S.B., and Weiner, L.P. 1986. Assignment of the human and mouse prion protein genes to homologous chromosomes. Proc. Natl. Acad. Sci. U.S.A. 83: 7358– 7362. CrossrefCASPubMedWeb of Science®Google Scholar 35Stahl, N., Borchelt, D.R., Hsiao, K., and Prusiner, S.B. 1987. Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 51: 229– 240. CrossrefCASPubMedWeb of Science®Google Scholar 36Stahl, N., Baldwin, M.A., Hecker, R., Pan, K.-M., Burlingame, A.L., and Prusiner, S.B. 1992. Glycosylinositol phospholipid anchors of the scrapie and cellular prion proteins contain sialic acid. Biochemistry 31: 5043– 5053. CrossrefCASPubMedWeb of Science®Google Scholar 37Tateishi, J., Tashima, T., and Kitamoto, T. 1991. Practical methods for chemical inactivation of Creutzfeldt-Jakob disease pathogen. Microbiol. Immunol. 35: 163– 166. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar 38Tateishi, J., and Kitamoto, T. 1993. Developments in diagnosis for prion diseases. Br. Med. Bull. 49: 971– 979. CrossrefCASPubMedWeb of Science®Google Scholar 39Tateishi, J., and Kitamoto, T. 1995. Inherited prion diseases and transmission to rodents. Brain Pathol. 5: 53– 59. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar 40Tateishi, J., Brown, P., Kitamoto, T., Hoque, Z.M., Roos, R., Wollman, R., Cervenáková, L., and Gajdusek, D.C. 1995. First experimental transmission of fatal familial insomnia. Nature 376: 434– 435. CrossrefCASPubMedWeb of Science®Google Scholar 41Telling, G.C., Scott, M., Hsiao, K.K., Foster, D., Yang, S.-L., Torchia, M., Sidia, K.C.L., Collinge, J., DeArmond, S.J., and Prusiner, S.B. 1994. Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein. Proc. Natl. Acad. Sci. U.S.A. 91: 9936– 9940. CrossrefCASPubMedWeb of Science®Google Scholar 42Westaway, D., and Prusiner, S.B. 1986. Conservation of the cellular gene encoding the scrapie prion protein. Nucleic Acids Res. 14: 2035– 2044. CrossrefCASPubMedWeb of Science®Google Scholar 43Westaway, D., DeArmond, S.J., Cayetano-Canlas, J., Groth, D., Foster, D., Yang, S.-L., Torchia, M., Carison, G.A., and Prusiner, S.B. 1994. Degeneration of skeletal muscle, peripheral nerve, and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell 76: 117– 129. CrossrefCASPubMedWeb of Science®Google Scholar 44Whittington, M.A., Sidle, K.C.L., Gowland, I., Meads, J., Hill, A.F., Palmer, M.S., Jefferys, G.R., and Collinge, J. 1995. Rescue of neurophysiological phenotype seen in PrP null mice by transgene encoding human prion protein. Nature Genet. 9: 197– 201. CrossrefCASPubMedWeb of Science®Google Scholar Citing Literature Volume39, Issue12December 1995Pages 923-928 ReferencesRelatedInformation
Referência(s)